Skip to main content
Image coming soon

Implementation-Focused AI in Pharmaceutical R&D Operations for Audit Teams

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Implementation-Focused AI in Pharmaceutical R&D Operations for Audit Teams

A 12-module mastery program for audit and compliance professionals advancing AI governance in drug development

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Audit teams face increasing pressure to validate complex AI models in R&D, without clear frameworks or tools to verify compliance systematically.

The situation this course is for

As AI systems become embedded in clinical trial design, compound selection, and safety forecasting, auditors are expected to assess model integrity, data provenance, and regulatory alignment, often without structured methodologies or operational playbooks. Traditional audit approaches fall short in dynamic, data-intensive R&D environments.

Who this is for

Compliance officers, internal auditors, and quality assurance leads in pharmaceutical or biotech organizations who need to evaluate and govern AI-driven R&D processes with precision and confidence.

Who this is not for

This course is not for data scientists building AI models, executives seeking high-level overviews, or professionals outside regulated life sciences R&D environments.

What you walk away with

  • Apply structured frameworks to audit AI models in drug discovery and development
  • Verify data lineage, model transparency, and validation rigor in R&D workflows
  • Align AI audit practices with evolving regulatory expectations (FDA, EMA, ICH)
  • Deploy standardized templates for AI system documentation and compliance reporting
  • Lead cross-functional coordination between data science, R&D, and audit functions

The 12 modules (with all 144 chapters)

Module 1. AI in Pharmaceutical R&D: Audit Context and Evolution
Foundational landscape of AI adoption in drug development and the expanding role of audit teams.
12 chapters in this module
  1. Overview of AI applications in drug discovery
  2. Regulatory trends shaping AI governance
  3. Audit function transformation in AI-enabled R&D
  4. Key stakeholders in AI validation workflows
  5. From manual review to systematic AI auditing
  6. Case study: AI-driven target identification audit
  7. Defining audit scope in early-phase R&D
  8. Understanding model development lifecycles
  9. Data sources and integration points in R&D
  10. Common risks in AI-assisted clinical design
  11. Audit readiness assessment framework
  12. Building cross-functional audit collaboration
Module 2. Governance Frameworks for AI in Regulated Environments
Establishing compliance-aligned oversight structures for AI systems in pharma.
12 chapters in this module
  1. Principles of AI governance in life sciences
  2. Mapping AI use cases to risk tiers
  3. Internal policy development for AI validation
  4. Aligning with GxP and ALCOA+ principles
  5. Audit charter expansion for AI systems
  6. Documenting model oversight responsibilities
  7. Third-party AI vendor governance
  8. Ethical review and bias mitigation protocols
  9. Change control for AI model updates
  10. Incident response planning for AI failures
  11. Audit trail requirements for algorithmic decisions
  12. Governance maturity assessment tool
Module 3. Model Validation and Verification for Auditors
Core techniques to assess model accuracy, reproducibility, and compliance.
12 chapters in this module
  1. Fundamentals of model validation in pharma
  2. Testing for overfitting and data leakage
  3. Reproducibility checks in computational workflows
  4. Validation of training and test data splits
  5. Performance metrics for classification models
  6. Audit trails for model development steps
  7. Version control and model registry review
  8. Validation of hyperparameter tuning
  9. Assessing model stability over time
  10. Cross-validation audit procedures
  11. Reviewing statistical assumptions in models
  12. Template: Model validation audit checklist
Module 4. Data Integrity and Provenance in AI Systems
Ensuring data quality, traceability, and regulatory compliance in AI pipelines.
12 chapters in this module
  1. ALCOA+ principles applied to AI data
  2. Data lineage mapping for algorithmic inputs
  3. Audit trails for data transformation steps
  4. Verifying source system authenticity
  5. Handling missing and imputed data
  6. Data quality thresholds in R&D models
  7. Audit of data labeling processes
  8. Reviewing data access and modification logs
  9. Ensuring temporal consistency in datasets
  10. Data governance in multi-site trials
  11. Audit of ETL processes in AI workflows
  12. Template: Data provenance audit worksheet
Module 5. Explainability and Transparency in Black-Box Models
Techniques to audit complex models and ensure interpretability for compliance.
12 chapters in this module
  1. Challenges of auditing deep learning models
  2. Model-agnostic explainability methods
  3. SHAP and LIME for regulatory reporting
  4. Audit documentation of model reasoning
  5. Validating surrogate models for interpretation
  6. Assessing feature importance consistency
  7. Explainability requirements under FDA guidance
  8. Communicating model logic to non-technical reviewers
  9. Audit of bias in feature selection
  10. Transparency in model decision thresholds
  11. Explainability in safety-critical predictions
  12. Template: Explainability audit report
Module 6. Regulatory Alignment: FDA, EMA, and ICH Guidelines
Navigating global regulatory expectations for AI in drug development.
12 chapters in this module
  1. Current FDA guidance on AI in clinical trials
  2. EMA perspective on machine learning validation
  3. ICH Q9 and risk-based approach to AI
  4. Software as a Medical Device (SaMD) considerations
  5. Audit documentation for regulatory submissions
  6. Inspection readiness for AI systems
  7. Labeling requirements for AI-driven decisions
  8. Post-market surveillance of AI models
  9. Auditing algorithmic updates under regulatory rules
  10. Harmonizing global AI compliance standards
  11. Regulatory interaction strategies for audit teams
  12. Template: Regulatory alignment checklist
Module 7. AI Audit Planning and Risk Assessment
Designing targeted audit plans for AI systems in R&D environments.
12 chapters in this module
  1. Risk-based audit planning for AI
  2. Identifying high-impact AI use cases
  3. Scoping audits for model development phases
  4. Stakeholder interviews in AI audits
  5. Document review protocols for AI projects
  6. Sampling strategies for algorithmic outputs
  7. Assessing model impact on patient safety
  8. Audit timing in agile development cycles
  9. Resource planning for technical audits
  10. Third-party audit coordination
  11. Audit program integration with QA systems
  12. Template: AI audit plan workbook
Module 8. Operationalizing AI Audits in R&D Workflows
Integrating audit practices into active drug development pipelines.
12 chapters in this module
  1. Embedding audit checkpoints in R&D phases
  2. Continuous monitoring of AI model performance
  3. Audit integration with electronic lab notebooks
  4. Real-time data validation techniques
  5. Collaboration with computational biology teams
  6. Audit of automated decision-making triggers
  7. Handling rapid prototyping in audits
  8. Version-aligned audit documentation
  9. Audit of cloud-based AI infrastructure
  10. Change management in live AI systems
  11. Audit frequency for iterative models
  12. Template: R&D workflow audit integration guide
Module 9. Bias, Fairness, and Equity in AI-Driven Research
Auditing for unintended discrimination in model design and outcomes.
12 chapters in this module
  1. Sources of bias in biomedical datasets
  2. Fairness metrics for clinical prediction models
  3. Audit of demographic representation in training data
  4. Evaluating model performance across subgroups
  5. Bias mitigation techniques in model design
  6. Audit of algorithmic impact on trial inclusion
  7. Equity considerations in drug response models
  8. Regulatory expectations for fairness
  9. Documentation of bias assessments
  10. Handling missing diversity data
  11. Audit of synthetic data generation
  12. Template: Bias audit assessment form
Module 10. AI Vendor and Third-Party Oversight
Auditing external AI solutions and managed services in R&D.
12 chapters in this module
  1. Due diligence for AI software vendors
  2. Audit of third-party model validation reports
  3. Contractual requirements for AI transparency
  4. Assessing vendor change control processes
  5. Audit of cloud AI platform compliance
  6. Data ownership and IP considerations
  7. Vendor risk classification frameworks
  8. Onsite vs. remote audit approaches
  9. Audit of API-based AI integrations
  10. Service level agreement review for AI systems
  11. Vendor incident reporting protocols
  12. Template: Third-party AI audit questionnaire
Module 11. Documentation and Reporting for AI Audits
Creating clear, compliant, and actionable audit outputs.
12 chapters in this module
  1. Structure of AI audit reports
  2. Documenting technical findings for regulators
  3. Visualizing model performance for reviewers
  4. Writing clear observations and recommendations
  5. Version-controlled audit documentation
  6. Secure storage of AI audit records
  7. Reporting to audit committees on AI risks
  8. Executive summaries for leadership
  9. Linking findings to corrective action plans
  10. Audit follow-up and closure processes
  11. Archiving AI audit materials for inspection
  12. Template: AI audit report generator
Module 12. Future-Proofing AI Audit Practices
Preparing for next-generation AI technologies and regulatory shifts.
12 chapters in this module
  1. Emerging trends in generative AI for drug design
  2. Auditing autonomous lab systems
  3. AI in real-world evidence generation
  4. Preparing for adaptive trial designs
  5. Blockchain for audit trail integrity
  6. Quantum computing implications for modeling
  7. Continuous learning model audits
  8. AI ethics board collaboration
  9. Building internal AI audit capability
  10. Professional development for AI auditors
  11. Staying current with regulatory updates
  12. Template: AI audit maturity roadmap

How this maps to your situation

  • Auditing AI in early-phase drug discovery
  • Validating models for clinical trial optimization
  • Ensuring compliance in AI-enhanced safety reporting
  • Overseeing third-party AI tools in regulatory submissions

Before vs. after

Before
Uncertain how to systematically audit AI models in R&D, relying on ad-hoc reviews and general compliance frameworks not designed for algorithmic systems.
After
Equipped with a structured, implementation-grade approach to validate AI models, ensure data integrity, and produce regulator-ready audit documentation.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 60, 70 hours of total engagement, designed for flexible, self-paced learning.

If nothing changes
Without a structured approach, audit teams risk overlooking critical model flaws, failing to meet evolving regulatory expectations, and being bypassed in strategic AI initiatives due to perceived lack of technical readiness.

How this compares to the alternatives

Unlike generic AI ethics courses or technical data science programs, this course is specifically designed for audit professionals in pharma R&D, combining regulatory insight, implementation tools, and audit-specific frameworks not available in academic or vendor-led training.

Frequently asked

Who is this course designed for?
Audit, compliance, and quality assurance professionals in pharmaceutical and biotech organizations who need to evaluate AI systems in drug development.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is prior AI experience required?
No, foundational concepts are covered, but the course is designed to build implementation-grade expertise for professionals with audit or compliance backgrounds.
$199 one-time. Approximately 60, 70 hours of total engagement, designed for flexible, self-paced learning..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!